Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2021-08-20 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
PR.20.08.21 - NL.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB shares were transferred to employees exercising stock options under long-term incentive plans. This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation/share schemes. This aligns precisely with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement ('gereglementeerde informatie') detailing these transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2021-08-20 Dutch
20210813 - Disposal of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposals of own shares" and details transactions where UCB disposed of its own shares OTC following stock option exercises under various Long Term Incentive Plans. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). The filing type code matching this description is 'POS' (Transaction in Own Shares). The document is a formal announcement dated August 13, 2021, and is short, suggesting it is a direct disclosure rather than a comprehensive report.
2021-08-13 English
20210813 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Disposal of own shares) and details transactions where UCB SA disposed of its own shares following the exercise of options by employees as part of long-term variable remuneration. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). This matches the definition for 'Transaction in Own Shares' (Code: POS). The document is a regulatory announcement dated August 13, 2021, detailing transactions that occurred between August 6 and August 12, 2021.
2021-08-13 French
20210813 - Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB shares were transferred to employees as part of long-term incentive plans (stock options). This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation/repurchase programs. This aligns perfectly with the definition of 'Transaction in Own Shares' (Code: POS). The document is a formal announcement dated August 13, 2021, detailing transactions from August 6 to August 12, 2021, and is not a general regulatory filing (RNS) or a report announcement (RPA), but the specific transaction disclosure itself.
2021-08-13 Dutch
210809 - Transparency notification press release FMR LLC .pdf
Major Shareholding Notification Classification · 1% confidence The document is a 'Transparency notification' from UCB SA/NV regarding a change in shareholding by FMR LLC, specifically noting that the holding crossed the 5% threshold on July 30, 2021. This type of filing, which reports changes in significant share ownership or insider transactions, aligns best with the 'Major Shareholding Notification' category (MRQ) or potentially 'Director's Dealing' (DIRS) if it were an executive, but since it is a major shareholder crossing a regulatory threshold, MRQ is the most precise fit among the provided options. It is not an Annual Report (10-K), Earnings Release (ER), or a general regulatory filing (RNS) because it describes a specific, reportable event under transparency laws.
2021-08-09 English
210809 - Notification de transparence comm. de presse FMR LLC .pdf
Major Shareholding Notification Classification · 1% confidence The document is a formal notification titled "Déclaration de transparence FMR LLC." It explicitly states that UCB SA received a transparency declaration from FMR LLC regarding the crossing of a significant shareholding threshold (5%). The content details the date the threshold was crossed (July 30, 2021), the resulting share count (9,728,407 shares, 5.00%), and lists the breakdown of voting rights held by related entities. This structure perfectly matches the definition of a Major Shareholding Notification, which reports changes in significant ownership levels crossing predefined thresholds.
2021-08-09 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.